Paliperidone Palmitate 3-Month Formulation
Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)
The University of Hong KongPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE University Hospital, Bonn | Phase 4 | BB |
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION University Hospital, Bonn | Phase 4 | BB |
Bxcl501 Washington University School of Medicine | Phase 4 | NR |
Same molecule, other indications
Paliperidone Palmitate 3-Month Formulation is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →